A detailed history of Pacer Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Pacer Advisors, Inc. holds 9,721 shares of TEVA stock, worth $170,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,721
Previous 10,196 4.66%
Holding current value
$170,117
Previous $143,000 9.79%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $6,070 - $8,265
-475 Reduced 4.66%
9,721 $157,000
Q1 2024

May 10, 2024

SELL
$10.67 - $14.43 $4,054 - $5,483
-380 Reduced 3.59%
10,196 $143,000
Q4 2023

Jan 16, 2024

BUY
$8.12 - $10.63 $2,387 - $3,125
294 Added 2.86%
10,576 $110,000
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $8,497 - $12,155
1,136 Added 12.42%
10,282 $104,000
Q2 2023

Jul 12, 2023

BUY
$7.2 - $9.47 $3,974 - $5,227
552 Added 6.42%
9,146 $68,000
Q1 2023

May 02, 2023

BUY
$8.36 - $11.37 $2,307 - $3,138
276 Added 3.32%
8,594 $76,000
Q4 2022

Feb 06, 2023

BUY
$7.95 - $9.48 $66,128 - $78,854
8,318 New
8,318 $75,000
Q1 2022

Apr 05, 2022

SELL
$7.33 - $9.39 $62,011 - $79,439
-8,460 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$7.9 - $10.19 $3,057 - $3,943
-387 Reduced 4.37%
8,460 $68,000
Q3 2021

Oct 15, 2021

BUY
$8.38 - $10.18 $2,312 - $2,809
276 Added 3.22%
8,847 $86,000
Q1 2021

Apr 05, 2021

SELL
$10.34 - $12.81 $4,756 - $5,892
-460 Reduced 5.09%
8,571 $99,000
Q4 2020

Jan 20, 2021

SELL
$8.61 - $11.04 $17,426 - $22,344
-2,024 Reduced 18.31%
9,031 $87,000
Q3 2020

Oct 19, 2020

BUY
$8.57 - $12.69 $94,741 - $140,287
11,055 New
11,055 $100,000
Q1 2020

Apr 23, 2020

SELL
$6.69 - $13.45 $55,747 - $112,078
-8,333 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$6.53 - $10.72 $20,334 - $33,382
3,114 Added 59.67%
8,333 $82,000
Q3 2019

Oct 10, 2019

BUY
$6.16 - $9.6 $10,841 - $16,896
1,760 Added 50.88%
5,219 $36,000
Q2 2019

Aug 12, 2019

BUY
$8.12 - $15.72 $28,087 - $54,375
3,459 New
3,459 $32,000
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $1.62 Million - $2.39 Million
-96,859 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $459,133 - $607,498
27,526 Added 39.7%
96,859 $1.66 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $330,442 - $562,017
29,425 Added 73.73%
69,333 $1.31 Million
Q3 2017

Nov 08, 2017

BUY
$15.41 - $32.17 $614,982 - $1.28 Million
39,908
39,908 $702,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.